Effectiveness of muscle basal lamina	1
Effectiveness	1
muscle basal lamina	18
neural stem cells	47
olfactory ensheathing cells	69
spinal cord repair X.W. Kang1 , J.L. Hu2 , S.K. Wang1 and J. Wang1	100
spinal cord repair X.W. Kang1	100
J.L. Hu2	132
S.K. Wang1	142
J. Wang1	157
1Department of Orthopedics	166
1Department	166
Orthopedics	181
Second Hospital of Lanzhou University	194
Second Hospital	194
Lanzhou University	213
Lan Zhou	233
China 2Department of Orthopedics	243
China 2Department	243
Orthopedics	264
The First Hospital of Baiyin City	277
The First Hospital	277
Baiyin City	299
Bansu	312
China ABSTRACT	319
We	338
the effect of muscle basal lamina -LRB- MBL -RRB-	350
the effect	350
muscle basal lamina -LRB- MBL -RRB-	364
muscle basal lamina	364
MBL	385
neural stem cells	395
NSCs	414
olfactory ensheathing cells	424
OECs	453
spinal cord injury repair	462
Seventy-two Sprague-Dawley rats	489
spinal cord hemisection	539
6 groups	580
blank control group -LRB- group A -RRB-	593
blank control group	593
group A	614
the ends of the spinal cord hemisection model	624
the ends	624
the spinal cord hemisection model	636
physiological saline	688
NSC transplantation group -LRB- B -RRB-	713
NSC transplantation group	713
B	740
OEC transplantation group -LRB- C -RRB-	744
OEC transplantation group	744
C	771
MBL with NSC transplantation group -LRB- D -RRB-	775
MBL	775
NSC transplantation group	784
D	811
MBL with OEC transplantation group -LRB- E -RRB-	815
MBL	815
OEC transplantation group	824
E	851
MBL with NSC	859
MBL	859
NSC	868
OEC transplantation group -LRB- F -RRB-	876
OEC transplantation group	876
F	903
NSCs , OECs , MBL with NSCs , MBL with OECs , and MBL with NSCs and OECs	907
NSCs , OECs	907
NSCs	907
OECs	913
MBL with NSCs	919
MBL	919
NSCs	928
MBL with OECs	934
MBL	934
OECs	943
MBL with NSCs and OECs	953
MBL	953
NSCs and OECs	962
the ends of the hemisection model	996
the ends	996
the hemisection model	1008
Survival and migration of transplanted cells	1031
Survival and migration	1031
transplanted cells	1057
immunohistochemistry and immunofluorescence	1093
4 and 8 weeks	1143
Hind limb function repair	1158
Bundle branch block score at various time points	1201
Bundle branch block score	1201
various time points	1230
surgery	1267
MBL	1276
NSC growth	1294
its lumen	1311
host cell advancement in the lumen	1333
host cell advancement	1333
the lumen	1358
local inflammatory responses	1378
MBL	1414
NSCs and/or OECs	1423
spinal cord repair	1444
advantages over simple cell transplantation	1469
advantages	1469
simple cell transplantation	1485
Group F	1514
nerve cells	1537
muscle basal lamina	1552
group E	1577
This method	1586
more axons , synaptic connections , and signal transduction pathways	1620
more axons	1620
synaptic connections	1632
signal transduction pathways	1658
these new axons	1697
nerve demyelination , which may greatly limit nerve signal conduction	1720
nerve demyelination	1720
nerve signal conduction	1765
group F	1793
OECs	1802
neural stem cells , axonal growth , and synaptic connection formation	1820
neural stem cells	1820
axonal growth	1839
synaptic connection formation	1858
its role	1893
INTRODUCTION	1915
recent years	1931
many studies	1945
the repair of spinal cord injury -LRB- SCI -RRB-	1972
the repair	1972
spinal cord injury -LRB- SCI -RRB-	1986
spinal cord injury	1986
SCI	2006
translation	2014
neural stem cells -LRB- NSCs -RRB-	2029
neural stem cells	2029
NSCs	2048
olfactory ensheathing cells -LRB- OECs -RRB-	2055
olfactory ensheathing cells	2055
OECs	2084
other cells	2094
Boido et al. , 2011 ; Amr et al. , 2014 ; Binan et al. , 2014	2107
Boido	2107
et al. , 2011 ; Amr et al. , 2014 ; Binan et al. , 2014	2113
et al. , 2011	2113
et al.	2113
2011	2121
Amr et al. , 2014	2127
Amr	2127
et al. , 2014	2131
et al.	2131
2014	2139
Binan et al. , 2014	2145
Binan	2145
et al. , 2014	2151
et al.	2151
2014	2159
the barrier function of glial scar	2186
the barrier function	2186
glial scar	2210
limited effects	2222
such methods -LRB- Binan et al. 2014 -RRB-	2262
such methods	2262
Binan	2276
et al. 2014	2282
et al.	2282
2014	2289
Muscle basal lamina -LRB- MBL -RRB- , a new scaffold material ,	2296
Muscle basal lamina -LRB- MBL -RRB-	2296
Muscle basal lamina	2296
MBL	2317
a new scaffold material	2323
the glial scar barrier	2358
the cavity	2391
axon guidance	2416
MBL	2437
an effective tool	2461
the difficulties caused by glial scars -LRB- Fansa et al. , 2002 -RRB-	2494
the difficulties	2494
glial scars -LRB- Fansa et al. , 2002 -RRB-	2521
glial scars	2521
Fansa	2534
et al. , 2002	2540
et al.	2540
2002	2548
this study	2558
we	2570
MBL	2581
NSCs and OECs	2594
the SCI site	2613
advantage of the ability of NSCs	2634
advantage	2634
the ability of NSCs	2647
the ability	2647
NSCs	2662
neurons	2689
the cavity	2705
the function	2728
OECs to provide and store nutritional molecules for the regenerated nerve	2744
nutritional molecules	2770
the regenerated nerve	2796
the	2796
nerve	2812
glial proliferation , scar formation , and myelinization	2830
glial proliferation	2830
scar formation	2851
myelinization	2871
We	2886
this method	2907
SCI repair	2933
this study	2959
we	2971
this complex	2982
both morphologic and functional examination	3008
the complex	3073
the repair process	3102
the mechanism	3141
MATERIAL	3157
METHODS Animals , reagents ,	3170
METHODS Animals	3170
reagents	3187
culture media Sprague-Dawley -LRB- SD -RRB- rats	3201
culture media Sprague-Dawley	3201
SD	3231
rats	3235
this study	3253
Male and female rats weighing 200-250 g	3265
Male and female rats	3265
200-250 g	3295
the Animal Experimental Center of Gansu College of Traditional Chinese Medicine	3322
the Animal Experimental Center	3322
Gansu College of Traditional Chinese Medicine	3356
Gansu College	3356
Traditional Chinese Medicine	3373
Details regarding the reagents and culture media	3403
Details	3403
the reagents and culture media	3421
special culture media for rat NSCs -LRB- containing 1:1 DMEM/F12 ,	3468
special culture media	3468
rat NSCs -LRB- containing 1:1 DMEM/F12 ,	3494
rat NSCs	3494
1:1 DMEM/F12	3515
2 % B27	3529
20 ng/mL basic fibroblast growth factor	3537
20 ng/mL basic fibroblast growth	3537
20 ng/mL	3537
basic fibroblast growth	3546
20 ng/mL epidermal growth factor	3578
20 ng/mL	3578
epidermal growth factor	3587
100 µg/mL penicillin , 100 µg/mL streptomycin	3616
100 µg/mL penicillin	3616
100 µg/mL streptomycin	3638
Gibco , Grand Island , NY , USA	3662
Gibco	3662
Grand Island	3669
NY	3683
USA	3687
nestin antibody -LRB- rabbit-anti-rat antibody -RRB-	3693
nestin antibody	3693
rabbit-anti-rat antibody	3710
5-bromodeoxyuridine -LRB- BrdU -RRB-	3737
5-bromodeoxyuridine	3737
BrdU	3758
primary antibodies -LRB- rabbit-anti-rat antibody ; Gibco -RRB-	3765
primary antibodies	3765
rabbit-anti-rat antibody ; Gibco	3785
rabbit-anti-rat antibody	3785
Gibco	3811
cell culture media	3819
cell	3819
10 % fetal bovine serum -LRB- Sigma , St. Louis , MO , USA -RRB-	3839
10 % fetal bovine serum	3839
Sigma	3863
St. Louis	3870
MO , USA	3881
0.25 % pancreatin -LRB- Sigma -RRB-	3891
0.25 % pancreatin	3891
Sigma	3909
P75 antibodies -LRB- rabbit-anti-rat antibody -RRB-	3917
P75 antibodies	3917
rabbit-anti-rat antibody	3933
fluorescein isothiocyanate -LRB- FITC -RRB- secondary antibodies	3960
fluorescein isothiocyanate	3960
FITC	3988
secondary antibodies	3994
goat-anti-rabbit antibody	4016
Hochest33342 ; neuron-specific enolase -LRB- NSE ; Sigma -RRB-	4044
Hochest33342 ; neuron-specific enolase	4044
Hochest33342	4044
neuron-specific enolase	4058
NSE ; Sigma	4083
NSE	4083
Sigma	4088
Immunohistochemistry Kit	4100
Maixin-Bio	4126
Ultra-Sensitive SP	4138
KIT-9701 , DouSPTM , KiT-9999	4158
Isolation , culture , and identification	4188
NSCs Embryonic SD rats at a gestational age of 14 weeks	4230
NSCs	4230
Embryonic SD rats at a gestational age of 14 weeks	4235
Embryonic SD rats	4235
a gestational age of 14 weeks	4256
a gestational age	4256
14 weeks	4277
the embryonic membrane	4319
we	4343
the brain	4354
isolated meninges and vessels	4373
a microscope -LRB- CX22 , Olympus Corporation -RRB-	4409
a microscope	4409
CX22	4423
Olympus Corporation	4429
the diencephalon	4457
The tissue	4489
phosphate-buffered saline	4525
This mixture	4569
a single-cell suspension using a 200-mesh cell screen	4596
a single-cell suspension	4596
a 200-mesh cell screen	4627
Culture media for rat NSCs	4651
Culture media	4651
rat NSCs	4669
the cells	4689
the cell concentration	4717
1.0 x 106/mL	4756
1.0	4756
106/mL	4762
The cells	4770
cell culture bottles	4794
5 % CO2	4832
37 °C -LRB- Thermo HERAcell 150i/240i , Thermo Fisher Scientific Inc. -RRB-	4843
Thermo HERAcell 150i/240i , Thermo Fisher Scientific Inc.	4849
Thermo HERAcell 150i/240i	4849
Thermo Fisher Scientific Inc.	4876
The culture medium	4908
every 3 days	4939
the suspension	4953
a disposable centrifuge tube	4982
5 min at 1000 g	5031
5 min	5031
1000 g	5040
The supernatant	5048
culture media	5079
the precipitate	5106
a total volume of 5 mL	5125
a total volume	5125
5 mL	5143
cells	5153
cell culture bottles	5173
Approximately 7 days	5195
the neurosphere diameter	5223
100 μm	5256
subculture	5280
We	5311
the suspension	5332
the supernatant	5378
we	5403
0.5-1 mL culture media and separation medium	5412
0.5-1 mL culture media	5412
separation medium	5439
5 min incubation at 37 °C	5464
5 min incubation	5464
37 °C	5484
we	5490
the singlecell neurosphere suspension	5502
we	5571
culture media	5580
the cells	5603
the cell concentration	5625
1.0 x 106/mL ,	5651
1.0	5651
106/mL	5657
the cells	5679
Thirdgeneration cells	5690
slides	5729
poly-L-lysine	5748
immunofluorescence -LRB- TriM Scop , LaVision BioTec GmbH , Germany -RRB-	5766
immunofluorescence	5766
TriM Scop , LaVision BioTec GmbH , Germany	5786
TriM Scop	5786
LaVision BioTec GmbH	5797
Germany	5819
analysis of the NSC-specific antigen nestin	5828
analysis	5828
the NSC-specific antigen nestin	5840
The primary antibody	5873
1:200 rabbit-anti-rat nestin	5898
the secondary antibody	5931
1:100 FITC goat-anti-rabbit fluorescent antibody	5958
1:100 FITC goat-anti-rabbit	5958
fluorescent antibody	5986
Isolation , culture , and identification of OECs	6008
Isolation , culture , and identification	6008
OECs	6050
selected rats	6069
we	6084
the skull	6094
the olfactory bulb	6114
meninges and vessels	6145
a microscope	6172
The olfactory bulb	6186
DMEM/F12	6226
a cell suspension	6239
0.25 % trypsinization	6277
5 min , which was terminated by adding 10 % fetal calf serum	6316
5 min	6316
10 % fetal calf serum	6354
The solution	6376
a 200-mesh cell screen	6410
3 min at 1000 r/min	6453
3 min	6453
1000 r/min	6462
the supernatant	6474
Culture medium	6505
the suspension for single-cell resuspension	6533
the suspension	6533
single-cell resuspension	6552
the concentration	6581
1.0 x 106/mL	6615
1.0	6615
106/mL	6621
Cells	6629
cell culture bottles for differential attachment culture and isolation	6652
cell culture bottles	6652
differential attachment culture and isolation	6677
this step	6731
the bottle	6742
each day , during which the adherent cells were discarded	6766
each day	6766
the adherent cells	6789
the suspended cells	6827
Two days later	6870
we	6886
AraC	6895
fibroblast growth	6912
cell purity	6931
90 %	6956
the 7th day , which was typical for cell culture and OEC identification	6963
the 7th day	6963
cell culture and OEC identification	6998
cell culture	6998
OEC identification	7015
Wells showing the highest purity	7035
Wells	7035
the highest purity	7049
further analysis	7082
Cells	7100
slides coated with poly-L-lysine for immunofluorescence analysis	7123
slides	7123
poly-L-lysine for immunofluorescence analysis	7142
poly-L-lysine	7142
immunofluorescence analysis	7160
A 1:100 dilution of rabbitanti	7189
A 1:100 dilution	7189
rabbitanti	7209
rat NGFR p75	7221
the primary antibody and 1:100 goat-anti-rabbit FITC	7238
the primary antibody	7238
1:100 goat-anti-rabbit FITC	7263
fluorescent antibody	7291
the secondary used for OECs	7316
the secondary	7316
OECs	7339
Specific operation	7345
the relevant instructions	7381
Preparation and identification	7408
MBL SD rats of either gender weighing 200-250 g	7442
MBL SD rats	7442
either gender weighing 200-250 g	7457
either gender	7457
200-250 g	7480
Rats	7505
intraperitoneal injection	7525
0.4 % pentobarbital sodium for anesthetization	7556
0.4 % pentobarbital sodium	7556
anesthetization	7586
the bilateral paravertebral muscles of the rats	7609
the bilateral paravertebral muscles	7609
the rats	7648
2	7685
x 2 x 1 cm strips	7687
2	7689
1 cm strips	7693
Muscle strips	7706
ultrapure water	7735
48 h in incubator shakers	7766
48 h	7766
incubator shakers	7774
50 rpm and 37 °C	7795
50 rpm	7795
37 °C	7806
they	7818
pure Triton X-100 solution	7842
48 h	7884
the same conditions	7901
samples	7922
1 % sodium dodecyl sulfate	7945
1 %	7945
sodium dodecyl sulfate	7948
another 48 h	7983
ultrapure water	8007
24 h	8035
phosphatebuffered saline	8051
another 24 h	8092
The muscle strips	8106
2	8138
x 2 x 1 cm3 sections	8140
2	8142
1 cm3 sections	8146
-20 °C	8175
use	8187
Some strips	8192
identification	8218
These samples	8234
4 % paraformaldehyde	8262
12 h	8286
pathological sectioning and hematoxylin and eosin staining	8304
pathological sectioning	8304
hematoxylin and eosin staining	8332
we	8373
the morphological changes of MBL	8385
the morphological changes	8385
MBL	8414
a microscope	8424
NSCs and the verifying	8447
NSCs	8447
the verifying	8456
We	8470
the well-growing 3rd generations	8482
15 µM BrdU	8529
the previous culture medium	8543
the cultures	8572
37 °C	8613
Some the labeled cells	8619
a 6-well plate	8657
attachment	8686
the slides	8702
poly-L-lysine	8725
the effectiveness of cellular labeling	8768
the effectiveness	8768
cellular labeling	8789
an immunofluorescence test	8813
In vitro culture and identification	8841
In vitro culture	8841
identification	8862
complex combining NSCs and MBL	8880
complex	8880
NSCs and MBL	8898
NSCs	8898
MBL	8907
The labeled NSC suspension	8911
a single-cell suspension	8970
the supernatant	9012
The prepared suspension	9029
MBL	9088
a 1-mL fine-needle injector	9098
disinfection	9131
MBL	9145
75 % alcohol overnight and washed with sterile phosphate-buffered saline	9166
75 % alcohol	9166
overnight	9178
sterile phosphate-buffered saline	9204
MBL	9239
the media on a 6-well plate for routine culture	9271
the media	9271
a 6-well plate for routine culture	9284
a 6-well plate	9284
routine culture	9303
Some of the complex	9320
Some	9320
the complex	9328
hematoxylin and eosin , immunohistochemistry , and immunofluorescence staining	9353
hematoxylin and eosin	9353
immunohistochemistry	9376
immunofluorescence staining	9402
the 3rd , 5th , and 7th days for identification	9433
the 3rd , 5th , and 7th days	9433
identification	9464
immunohistochemistry staining	9484
1:200 rabbitanti - rat BrdU	9515
1:200 rabbitanti	9515
rat BrdU	9533
the primary antibody and goat-anti-rabbit	9554
the secondary antibody	9614
immunohistochemistry staining	9642
1:200 rabbit-anti-rat BrdU	9673
the primary antibody	9712
the secondary	9740
1:100 FITC goat-anti-rabbit fluorescent antibody	9758
1:100 FITC goat-anti-rabbit	9758
fluorescent antibody	9786
All operations	9808
the instructions	9847
OECs with Hochest33342	9874
OECs	9874
Hochest33342	9884
well-growing OECs	9911
10 µM Hochest33342	9930
the culture medium	9962
4 h at 37 °C	9999
4 h	9999
37 °C	10006
In vitro culture	10012
identification of complex of OECs and MBL The combination procedure	10033
identification	10033
complex of OECs and MBL The combination procedure	10051
complex of OECs	10051
complex	10051
OECs	10062
MBL The combination procedure	10071
MBL	10071
The combination procedure	10075
the same as that used for NECs and MBL	10105
the same	10105
that used for NECs and MBL	10117
that	10117
NECs and MBL	10131
NECs	10131
MBL	10140
The complex	10145
the 3rd , 5th , and 8th days	10184
the 3rd	10184
5th	10193
8th days	10202
immunofluorescence staining	10214
OEC proliferation	10254
MBL	10275
A 6-µm frozen section of the complex	10280
A 6-µm frozen section	10280
the complex	10305
glycerin	10364
samples	10374
ultraviolet radiation	10402
a microscope	10438
Cells displaying blue fluorescence	10452
Cells	10452
blue fluorescence	10469
OECs	10492
In vitro culture and identification of complex of NSCs , OECs , and MBL First	10498
In vitro culture	10498
identification of complex of NSCs , OECs , and MBL First	10519
identification	10519
complex of NSCs , OECs , and MBL First	10537
complex	10537
NSCs , OECs , and MBL First	10548
NSCs	10548
OECs	10554
MBL First	10564
we	10575
the injection and combination	10588
the 3 cell types using the method described above	10621
the 3 cell types	10621
the method described above	10644
the method	10644
the samples	10680
a 6-well plate for routine culture -LRB- completely submerged in the media -RRB-	10707
a 6-well plate	10707
routine culture	10726
the media	10767
the 3rd , 5th , and 7th days	10782
the complex	10810
hematoxylin and eosin , immunohistochemistry , and immunofluorescence staining	10840
hematoxylin and eosin	10840
immunohistochemistry	10863
immunofluorescence staining	10889
hemisection SCI modeling	10928
transplantation Seventy-two rats from the same litter	10958
transplantation	10958
Seventy-two rats from the same litter	10974
Seventy-two rats	10974
the same litter	10996
a blank control group -LRB- group A -RRB-	11042
a blank control group	11042
group A	11065
NSCs only group -LRB- group B -RRB-	11075
NSCs	11075
only group -LRB- group B -RRB-	11080
only group	11080
group B	11092
OECs only group -LRB- group C -RRB-	11102
OECs	11102
only group -LRB- group C -RRB-	11107
only group	11107
group C	11119
NSCs + MBL group -LRB- group D -RRB- , OECs + MBL group -LRB- group E -RRB-	11129
NSCs	11129
MBL group -LRB- group D -RRB- , OECs + MBL group -LRB- group E -RRB-	11136
MBL group -LRB- group D -RRB- , OECs	11136
MBL group	11136
group D	11147
OECs	11157
MBL group -LRB- group E -RRB-	11164
MBL group	11164
group E	11175
NSCs + OECs + MBL group -LRB- group F -RRB-	11189
NSCs + OECs	11189
NSCs	11189
OECs	11196
MBL group -LRB- group F -RRB-	11203
MBL group	11203
group F	11214
a randomized digital table	11229
a	11229
digital table	11242
Each group	11257
12 rats	11277
Rats	11286
intraperitoneal injection	11312
0.4 % pentobarbital sodium and cut layer-by-layer along the dorsal median line	11341
0.4 % pentobarbital sodium and cut layer-by-layer	11341
the dorsal median line	11396
We	11420
the spinous process and vertebral plate of T10	11430
the spinous process and vertebral plate	11430
T10	11473
the spinal dura mater	11487
a longitudinal incision	11522
we	11553
the right spinal cord	11568
an iridectome	11596
1 mm long spinal cord from the ends	11622
1 mm long spinal cord	11622
1 mm	11622
the ends	11649
rats in group A	11663
rats	11663
group A	11671
incisions	11680
layer-by-layer	11702
normal saline	11736
groups B and C	11754
groups B	11754
C	11767
we	11770
1.0 x 106/mL of the corresponding suspension	11782
1.0	11782
106/mL of the corresponding suspension	11788
106/mL	11788
the corresponding suspension	11798
the injured spinal cord site	11832
a fine needle injector	11867
the dura mater	11904
the cut	11935
groups D , E , and F	11947
groups D	11947
E	11957
F	11964
the 1 x 1 x 1 mm complex	11967
1	11971
1 x 1 mm complex	11975
1	11975
1 mm complex	11979
the injured	12007
the dura matter and incision	12024
One week	12071
we	12087
penicillin	12099
day	12119
bladder massaging twice -LRB- once in the morning and once in the evening -RRB-	12137
bladder massaging twice	12137
bladder	12137
the morning	12170
the evening	12194
each day	12207
urination	12220
Assessment of locomotor function and morphological changes Locomotor function	12231
Assessment of locomotor function	12231
Assessment	12231
locomotor function	12245
morphological changes Locomotor function	12268
morphological changes	12268
Locomotor function	12290
the Basso , Beattie , and Bresnahan rank scale -LRB- BBB -RRB-	12346
the Basso	12346
Beattie	12357
Bresnahan rank scale	12370
BBB	12392
the day	12401
transplantation	12416
the 2nd , 4th , and 8th days after transplantation	12439
the 2nd , 4th , and 8th days	12439
transplantation	12472
the recovery of locomotor function of rats ' hind legs	12489
the recovery	12489
locomotor function of rats ' hind legs	12505
locomotor function	12505
rats ' hind legs	12527
rats '	12527
2 persons using an improved method	12574
2 persons	12574
an improved method	12590
We	12610
the average of the results	12624
the average	12624
the results	12639
Morphological changes	12652
pathological sections	12694
Four rats	12717
each group at the 4th and 8th weeks	12746
each group	12746
the 4th and 8th weeks	12760
the surgery	12788
Their spinal cords	12801
heart perfusion	12834
paraformaldehyde	12856
30 %	12897
sucrose solution overnight	12901
sucrose solution	12901
overnight	12918
all spinal cords	12935
immunohistochemistry and immunofluorescence	12968
later observation	13016
microscopes	13040
spinal cords in group F	13064
spinal cords	13064
group F	13080
double - immunohistochemistry using the DouSPTM Kit	13106
double	13106
immunohistochemistry using the DouSPTM Kit	13114
immunohistochemistry	13114
the DouSPTM Kit	13141
staining	13158
the manufacturer instructions	13194
Staining	13225
`` BrdU + P75 ''	13264
`` BrdU	13264
P75	13272
BrdU-positive cells	13278
the nucleus	13314
P75-positive staining cells	13347
the cytoplasm or membranes	13391
the cytoplasm	13391
membranes	13408
color	13434
the `` NSE + BrdU ''	13445
the `` NSE	13445
BrdU	13456
NSE-positive cells	13463
the cytoplasm or membranes	13498
the cytoplasm	13498
membranes	13515
color	13541
BrdU-positive cells	13548
the nucleus	13584
Electron microscopy observation	13617
1 rat from group F	13667
1 rat	13667
group F	13678
the spinal cord	13692
heart perfusion	13726
glutaraldehyde	13748
glutaraldehyde overnight	13782
Samples	13808
transmission electron microscopy and scanning electron microscopy	13833
transmission electron microscopy	13833
scanning electron microscopy	13870
Statistical analysis Statistical analysis	13900
Statistical analysis	13900
Statistical analysis	13921
SPSS version 17.0 -LRB- SPSS , Inc. , Chicago , IL , USA -RRB-	13962
SPSS version 17.0	13962
SPSS , Inc. , Chicago , IL , USA	13981
SPSS	13981
Inc.	13987
Chicago	13993
IL	14002
USA	14006
BBB scores	14012
means	14039
standard deviation	14047
The t-test	14067
intergroup comparison	14094
Differences	14117
statistically significant when P <	14151
statistically significant	14151
P	14182
RESULTS Table 1 .	14193
RESULTS	14193
Table 1	14201
BBB scores	14210
6 groups at each point after surgery -LRB- means ± SD , point -RRB-	14224
6 groups	14224
each point after surgery	14236
each point	14236
surgery	14253
means	14262
SD , point	14270
SD	14270
point	14274
Table 2 .	14283
Table	14283
2	14289
Statistical results for BBB scores between each group .	14292
Statistical results	14292
BBB scores	14316
each group	14335
Figure 1 .	14348
Figure	14348
1	14355
Primary	14358
NSCs for 7 days -LRB- 10X -RRB-	14375
NSCs	14375
7 days -LRB- 10X -RRB-	14384
7 days	14384
10X	14392
Figure 2 .	14399
Figure	14399
2	14406
A. Bright field -LRB- 10X -RRB- .	14409
A. Bright field	14409
10X	14426
B. Identified using immunofluorescence	14432
B. Identified	14432
immunofluorescence	14452
ultraviolet light	14480
primary anti-nestin , secondary antibody	14503
FITC	14544
DAPI staining of nuclei , blue fluorescence , 200 μm	14570
DAPI staining	14570
nuclei , blue fluorescence , 200 μm	14587
nuclei	14587
blue fluorescence , 200 μm	14595
blue fluorescence	14595
200 μm	14614
Figure 3 .	14623
Figure	14623
3	14630
Primary OEC identification	14633
immunofluorescence	14666
P75 -LRB- 40X -RRB- -LRB- Blu-ray excitation -RRB-	14694
P75 -LRB- 40X -RRB-	14694
P75	14694
40X	14699
Blu-ray excitation	14705
Figure 4 .	14727
Figure	14727
4	14734
MBL hematoxylin and eosin staining -LRB- 40X -RRB- .	14737
MBL hematoxylin and eosin staining	14737
40X	14773
Figure 5 .	14780
Figure	14780
5	14787
NSCs	14790
BrdU	14807
Figure 6 .	14814
Figure	14814
6	14821
NSCs in the MBL .	14824
NSCs	14824
the MBL	14832
Results for hematoxylin and eosin staining	14841
Results	14841
hematoxylin and eosin staining	14853
A. Three days after translation .	14904
A.	14904
Three days	14907
translation	14924
B. Five days after translation .	14937
B.	14937
Five days	14940
translation	14956
C. Seven days after translation .	14969
C.	14969
Seven days	14972
translation	14989
Figure 7 .	15003
Figure	15003
7	15010
NSCs in the MBL .	15013
NSCs	15013
the MBL	15021
A. Immunohistochemistry -LRB- 40X -RRB- .	15030
A. Immunohistochemistry	15030
40X	15055
B. Immunofluorescence -LRB- 40X -RRB- .	15061
B. Immunofluorescence	15061
40X	15084
Figure 8 .	15091
Figure	15091
8	15098
OECs in the MBL	15101
OECs	15101
the MBL	15109
immunofluorescence -LRB- 40X ; excited by ultraviolet light -RRB-	15131
immunofluorescence	15131
40X ;	15151
40X	15151
excited by ultraviolet light	15156
excited	15156
ultraviolet light	15167
Figure 9 .	15188
Figure	15188
9	15195
Identification of NSCs + OECs in the MBL	15198
Identification	15198
NSCs + OECs	15216
the MBL	15231
immunofluorescence -LRB- 10X ; excited by ultraviolet light -RRB-	15245
immunofluorescence	15245
10X ;	15265
10X	15265
excited by ultraviolet light	15270
excited	15270
ultraviolet light	15281
Figure 10 .	15302
Figure	15302
10	15309
Group A , 4 weeks after surgery -LRB- immunohistochemistry , 40X -RRB- .	15313
Group A	15313
4 weeks after surgery -LRB- immunohistochemistry , 40X -RRB-	15322
4 weeks	15322
surgery -LRB- immunohistochemistry , 40X -RRB-	15336
surgery	15336
immunohistochemistry , 40X	15345
immunohistochemistry	15345
40X	15367
Figure 11 .	15374
Figure	15374
11	15381
Group B , 4 weeks after surgery -LRB- immunohistochemistry , 40X -RRB- .	15385
Group B	15385
4 weeks after surgery -LRB- immunohistochemistry , 40X -RRB-	15394
4 weeks	15394
surgery -LRB- immunohistochemistry , 40X -RRB-	15408
surgery	15408
immunohistochemistry , 40X	15417
immunohistochemistry	15417
40X	15439
Figure 12 .	15446
Figure	15446
12	15453
Group C	15457
4 weeks	15466
surgery -LRB- immunofluorescence , 10X , excited by ultraviolet light -RRB-	15480
surgery	15480
immunofluorescence , 10X , excited by ultraviolet light	15489
immunofluorescence	15489
10X , excited by ultraviolet light	15509
10X	15509
ultraviolet light	15525
Figure 13 .	15546
Figure	15546
13	15553
Group D	15557
4 weeks	15566
surgery -LRB- immunofluorescence , excited by ultraviolet light -RRB-	15580
surgery	15580
immunofluorescence , excited by ultraviolet light	15589
immunofluorescence	15589
excited by ultraviolet light	15609
excited	15609
ultraviolet light	15620
A. Cross section -LRB- 40X -RRB- .	15640
A. Cross section	15640
40X	15658
B. Vertical section -LRB- 40X -RRB- .	15664
B. Vertical section	15664
40X	15685
Figure 14 .	15692
Figure	15692
14	15699
Group D , 4 weeks after surgery -LRB- immunohistochemistry , 40X -RRB- .	15703
Group D	15703
4 weeks after surgery -LRB- immunohistochemistry , 40X -RRB-	15712
4 weeks	15712
surgery -LRB- immunohistochemistry , 40X -RRB-	15726
surgery	15726
immunohistochemistry , 40X	15735
immunohistochemistry	15735
40X	15757
A. Cross section -LRB- 40X -RRB- .	15763
A. Cross section	15763
40X	15781
B. Vertical section -LRB- 40X -RRB- .	15787
B. Vertical section	15787
40X	15808
Figure 15 .	15815
Figure	15815
15	15822
Group E , 4 weeks after surgery -LRB- 40X -RRB- .	15826
Group E	15826
4 weeks after surgery -LRB- 40X -RRB-	15835
4 weeks	15835
surgery -LRB- 40X -RRB-	15849
surgery	15849
40X	15858
A. Immunofluorescence .	15864
A.	15864
Immunofluorescence	15867
B. Immunohistochemistry .	15887
B.	15887
Immunohistochemistry	15890
Figure 16 .	15913
Figure	15913
16	15920
Group F	15924
4 weeks	15933
surgery	15947
immunofluorescence , 10X ; OECs excited by ultraviolet are blue , NSCs are green	15956
immunofluorescence	15956
10X ; OECs excited by ultraviolet are blue , NSCs are green	15976
10X	15976
OECs excited by ultraviolet	15981
OECs	15981
ultraviolet	15997
NSCs	16019
Figure 17 .	16037
Figure	16037
17	16044
Group F immunohistochemical double staining .	16048
Group F	16048
immunohistochemical double staining	16056
BrdU + cells	16093
BrdU	16093
cells	16099
P75 + cells	16120
P75	16120
cells	16125
Figure 18 .	16141
Figure	16141
18	16148
Group F immunohistochemical double staining .	16152
Group F	16152
immunohistochemical double staining	16160
BrdU + cells	16197
BrdU	16197
cells	16203
NSE + cells	16224
NSE	16224
cells	16229
Figure 19 .	16245
Figure	16245
19	16252
Scanning electron microscopy images of group F 4 weeks after surgery .	16256
Scanning electron microscopy images	16256
group F 4 weeks after surgery	16295
group F	16295
4 weeks	16303
surgery	16317
Figure 20 .	16327
Figure	16327
20	16334
TEM images of group F 4 weeks after surgery .	16338
TEM images	16338
group F 4 weeks	16352
group F	16352
4 weeks	16360
surgery	16374
Primary culture and identification	16384
NSCs After culture for 7 days , primary NSCs	16422
NSCs	16422
culture for 7 days , primary NSCs	16433
culture	16433
7 days , primary NSCs	16445
7 days	16445
primary NSCs	16453
a neural sphere	16478
a diameter of nearly 100 µm , which consisted of tens to hundreds of cells	16499
a diameter	16499
nearly 100 µm , which consisted of tens to hundreds of cells	16513
nearly 100 µm	16513
tens	16547
hundreds of cells	16555
hundreds	16555
cells	16567
The sphere	16574
no obvious bulge and good refractivity -LRB- Figure 1 -RRB-	16592
no obvious bulge and good refractivity	16592
Figure 1	16632
The results of immunofluorescence	16643
The results	16643
immunofluorescence	16658
primary cultured NSCs in our study	16690
primary	16690
NSCs in our study	16707
NSCs	16707
our study	16715
Figure 2A-B	16747
Primary culture and identification of OECs An increase in primary OECs	16761
Primary culture and identification	16761
OECs An increase	16799
OECs	16799
An increase	16804
primary OECs	16819
the 3rd day	16848
Most cells	16861
small neurites and bipolar cells	16882
small neurites	16882
bipolar cells	16901
the 4th day	16946
bipolar cells with thin and outstretched neuritis	16959
bipolar cells	16959
thin and outstretched neuritis	16978
few multipolar cells	17027
the 7th day	17066
adherent bipolar and multipolar cells	17079
reticular and NGFR p75 - positive -LRB- Figure 3 -RRB-	17137
reticular and NGFR p75 - positive	17137
reticular and NGFR p75	17137
Figure 3	17171
Evaluation of MBL Microscopically , orderly arranged	17182
Evaluation of MBL Microscopically	17182
Evaluation	17182
MBL Microscopically	17196
MBL	17196
orderly arranged	17217
orderly	17217
equally eosinophilic basement membrane components	17238
muscle cells	17309
Tiny	17340
a diameter in the micron range	17357
a diameter	17357
the micron range	17371
adjacent basement membranes	17408
channels	17456
the migration and adhesion of transplanted cells -LRB- Figure 4 -RRB-	17469
the migration and adhesion	17469
transplanted cells -LRB- Figure 4 -RRB-	17499
transplanted cells	17499
Figure 4	17519
Examination of NSCs	17530
Examination	17530
NSCs	17545
BrdU	17563
The nucleus	17568
green fluorescence	17587
Nuclei	17629
long and thin neuritis and good refractivities	17645
more than 95 %	17697
Figure 5	17731
Identification of complex of MBL and NSCs Sections	17742
Identification	17742
complex of MBL and NSCs Sections	17760
complex	17760
MBL and NSCs Sections	17771
NSCs	17800
MBL	17832
The complex	17837
the most	17859
cells	17868
the 5th day	17877
transplantation	17895
the 7th day -LRB- Figures 6A-C and 7A-B -RRB-	17934
the 7th day	17934
Figures 6A-C and 7A-B	17947
Evaluation	17971
complex	17985
MBL and OECs	17996
cultivated for 5 days , OECs	18014
cultivated	18014
5 days , OECs	18029
5 days	18029
OECs	18037
the MBL	18069
The density of OECs on the 7th day	18078
The density	18078
OECs on the 7th day	18093
OECs	18093
the 7th day	18101
the 5th day	18132
no additional changes	18149
the 9th day -LRB- Figure 8 -RRB-	18188
the 9th day	18188
Figure 8	18201
Examination	18212
complex	18227
NECs , OECs , and MBL Immunofluorescence microscopy	18238
NECs	18238
OECs	18244
MBL Immunofluorescence microscopy	18254
5 days	18307
NSCs with green fluorescence and OECs with blue fluorescence	18326
NSCs	18326
green fluorescence and OECs with blue fluorescence	18336
green fluorescence and OECs	18336
blue fluorescence	18369
the MBL	18403
ultraviolet radiation -LRB- Figure 9 -RRB-	18427
ultraviolet radiation	18427
Figure 9	18450
Morphological changes	18461
operation	18498
Group A	18511
fibrillar connective tissues	18520
injured tissue death and cavity formation -LRB- Figure 10 -RRB-	18576
injured tissue death and cavity formation	18576
Figure 10	18619
Group B	18634
we	18643
a relatively larger cavity	18655
the injury site	18685
few NSCs	18702
a severe inflammatory response	18712
obvious inflammatory cell infiltration	18744
numerous fibrous scars -LRB- Figure 11 -RRB-	18788
numerous fibrous scars	18788
Figure 11	18812
the 4th week	18826
Group C	18843
nerve fiber cells	18871
inflammatory cell infiltration	18927
Figure 12	18975
Group D	18990
immunofluorescence	18999
the 4th week	19032
NSCs	19049
the cranial to the caudal site -LRB- Figure 13A-B -RRB-	19103
the cranial to the caudal site	19103
the caudal site	19118
Figure 13A-B	19135
Immunohistochemical results	19150
transplanted cells in the MBL	19190
transplanted cells	19190
the MBL	19212
the caudal side	19238
host cells	19259
the MBL	19283
addition	19295
we	19305
grey and white matter	19317
clear boundaries	19344
the lacerated ends	19364
the nerve fibers	19384
the areas	19417
necrosis	19440
the cystic cavity	19450
the transplanted cells	19500
normal tissue around them -LRB- Figure 14A-B -RRB-	19547
normal tissue	19547
them -LRB- Figure 14A-B -RRB-	19568
them	19568
Figure 14A-B	19574
Group E	19592
immunohistochemistry and immunofluorescence	19601
the 4th week	19656
OECs	19683
myelin sheath	19699
nerve fiber synapses	19720
the transplanted areas	19764
Few inflammatory cells and no obvious inflammatory infiltration	19788
Few inflammatory cells	19788
no obvious inflammatory infiltration	19815
Figure 15A-B	19867
Group F	19885
pathological sections at the 4th week	19894
pathological sections	19894
the 4th week	19919
fiber scars	19939
sporadic inflammatory cells	19955
polygonal cells	19984
small round cells	20005
the lacerated ends	20026
BrdU-positive NSCs	20057
P75-positive OECs	20080
immunohistochemistry and immunofluorescence double staining	20110
Figures 16 and 17	20171
immunohistochemical double staining of NSE and BrdU	20205
immunohistochemical double staining	20205
NSE and BrdU	20244
NSE	20244
BrdU	20252
some of the double-positive cells	20272
some	20272
the double-positive cells	20280
neurons	20311
BrdU-labeled neural stem cells -LRB- Figure 18 -RRB-	20345
BrdU-labeled neural stem cells	20345
Figure 18	20377
Electron microscopy results	20389
post-surgery samples	20420
Group F	20444
MBL in the site of injury	20453
MBL	20453
the site of injury	20460
the site	20460
injury	20472
scanning electron microscopy	20506
the 4th week	20546
they	20564
the site of injury	20585
the site	20585
injury	20597
a honeycomb pattern -LRB- Figure 19A -RRB-	20607
a honeycomb pattern	20607
Figure 19A	20628
New neurons and their axons	20641
New neurons	20641
their axons	20657
the connective area of the MBL and spinal cord ; moreover	20698
the connective area	20698
the MBL and spinal cord ; moreover	20721
the MBL and spinal cord	20721
the MBL	20721
spinal cord	20733
nerve fiber bundles passed through this area -LRB- Figure 19B -RRB-	20756
nerve fiber bundles	20756
this area -LRB- Figure 19B -RRB-	20791
this area	20791
Figure 19B	20802
Transmission electron microscopy	20815
neurons containing Nissl bodies	20860
neurons	20860
Nissl bodies	20879
synapses and axons	20914
demyelination of the outer layers of the axons	20943
demyelination	20943
the outer layers of the axons	20960
the outer layers	20960
the axons	20980
Figure 20A-C	21009
Locomotor function assessment after transplantation and statistical analysis	21024
Locomotor function assessment	21024
transplantation and statistical analysis	21060
surgery	21108
rats in each group	21117
rats	21117
each group	21125
21	21148
BBB	21164
Three days	21169
surgery	21186
1 rat from group A	21195
1 rat	21195
group A	21206
urinary tract infections	21222
We	21274
statistical analysis	21287
the data of remaining rats	21311
the data	21311
remaining rats	21323
Details	21339
Tables 1 and 2	21360
DISCUSSION Recent pathological studies	21377
DISCUSSION	21377
Recent pathological studies	21388
the difficulties of functional recovery after SCI	21436
the difficulties	21436
functional recovery after SCI	21456
functional recovery	21456
SCI	21482
the survival of cells	21502
the survival	21502
cells	21518
regeneration of axons	21525
regeneration	21525
axons	21541
the precise location of regenerative axons	21548
the precise location	21548
regenerative axons	21572
accurate reformation and functional synaptic connections	21596
Nandoe Tewarie	21654
et al. , 2009	21669
et al.	21669
2009	21677
NSCs	21692
neurons -LRB- Lee et al. , 2012 -RRB-	21738
neurons	21738
Lee	21747
et al. , 2012	21751
et al.	21751
2012	21759
oligodendrocytes	21766
axons -LRB- Decimo et al. , 2011 ; Yasuda et al. , 2011 -RRB-	21788
axons	21788
Decimo	21795
et al. , 2011 ; Yasuda et al. , 2011	21802
et al.	21802
2011 ; Yasuda et al.	21810
2011	21810
Yasuda et al.	21816
Yasuda	21816
et al.	21823
2011	21831
the spinal cord cavity	21871
host spinal cord tissues	21909
Boido	21935
et al. , 2011 ; Li et al. , 2011	21941
et al.	21941
2011 ; Li et al.	21949
2011	21949
Li et al.	21955
Li	21955
et al.	21958
2011	21966
they	21973
SCI	22006
Animal experiments	22011
the regenerated axon	22050
ability	22083
fiber scars	22100
new neural pathways	22122
the internal environment of the organism	22150
the internal environment	22150
the organism	22178
the survival and differentiation	22199
NSCs	22235
Lian Jin	22241
et al. , 2011	22250
et al.	22250
2011	22258
Meng et al. , 2011	22264
Meng	22264
et al. , 2011	22269
et al.	22269
2011	22277
Su et al. , 2011	22283
Su	22283
et al. , 2011	22286
et al.	22286
2011	22294
Wang et al. , 2011	22300
Wang	22300
et al. , 2011	22305
et al.	22305
2011	22313
Wakai et al. , 2014	22319
Wakai	22319
et al. , 2014	22325
et al.	22325
2014	22333
limited effects	22351
the repair using only NSCs	22389
the repair	22389
only NSCs	22406
2 critical issues	22423
the effectiveness of NSC transplantation	22472
the effectiveness	22472
NSC transplantation	22493
SCI repair	22517
a passage location for axon growth	22536
a passage location	22536
axon growth	22559
Amr et al. , 2014 ; Binan et al. , 2014 ; Pera et al. , 2014	22591
Amr	22591
et al. , 2014 ; Binan et al. , 2014 ; Pera et al. , 2014	22595
et al. , 2014	22595
et al.	22595
2014	22603
Binan et al. , 2014	22609
Binan	22609
et al. , 2014	22615
et al.	22615
2014	22623
Pera et al. , 2014	22629
Pera	22629
et al. , 2014	22634
et al.	22634
2014	22642
second , a stable microenvironment rich in nutrients and nerve growth factors	22649
a stable microenvironment	22657
nutrients and nerve	22691
Paczkowska	22745
al. , 2013 ; Uesaka et al. , 2013 ; Ladewig et al. , 2014 ; Shin et al. , 2014	22759
al. , 2013 ; Uesaka et al. , 2013 ; Ladewig et al. , 2014 ; Shin et al.	22759
al. , 2013	22759
al.	22759
2013	22764
Uesaka et al. , 2013	22770
Uesaka	22770
et al. , 2013	22777
et al.	22777
2013	22785
Ladewig et al. , 2014	22791
Ladewig	22791
et al. , 2014	22799
et al.	22799
2014	22807
Shin et al.	22813
Shin	22813
et al.	22818
2014	22826
MBL	22833
a new scaffold material	22840
a natural biomaterial	22871
muscle cells	22910
panniculus adiposus	22924
membrane-associated antigens	22945
soluble protein	22979
MBL	22996
the neural membrane tube	23014
It	23040
good biocompatibility with nervous tissue	23049
good biocompatibility	23049
nervous tissue	23076
good contact orientation function	23102
the first limitation described before	23153
the first limitation	23153
studies	23201
transplantation of MBL	23223
transplantation	23223
MBL	23242
autolysisprone	23256
MBL	23292
nerve growth factors	23310
autolysis -LRB- Krenz and Weaver , 2000 -RRB-	23339
autolysis	23339
Krenz and Weaver	23350
2000	23368
OEC	23375
a special glial cell existing	23382
the olfactory epithelium	23415
olfactory nerve -LRB- Ekberg and St. John , 2014 -RRB-	23444
olfactory nerve	23444
Ekberg and St. John , 2014	23461
Ekberg	23461
St. John , 2014	23472
St. John	23472
2014	23482
It	23489
the peripheral nervous system and central nervous system	23512
the peripheral nervous system	23512
central nervous system	23546
shares	23573
Schwann cell and astrocytes -LRB- Montgomery et al. , 1996 -RRB-	23595
Schwann cell and astrocytes	23595
Montgomery	23624
et al. , 1996	23635
et al.	23635
1996	23643
OEC	23650
brain-derived neurotrophic factor	23666
glial cell line-derived neurotrophic factor	23704
glial cell	23704
line-derived neurotrophic factor	23715
others	23755
the regeneration	23784
synapses	23804
Lu and Waite	23814
Lu	23814
Waite	23821
1999	23828
Fairless and Barnett , 2005	23834
Fairless and Barnett	23834
2005	23856
King-Robson , 2011	23862
King-Robson	23862
2011	23875
Kerever at al. , 2014	23881
Kerever	23881
al. , 2014	23892
al.	23892
2014	23897
Li et al. , 2014	23903
Li	23903
et al. , 2014	23906
et al.	23906
2014	23914
addition	23924
cell adhesion molecules and adhesive glycoproteins	23934
cell adhesion molecules	23934
adhesive glycoproteins	23962
OECs	24003
a positive effect on axon growth and tunica vaginalis formation outside of axons	24017
a positive effect on axon growth	24017
a positive effect	24017
axon growth	24038
tunica vaginalis formation outside of axons	24054
tunica vaginalis formation	24054
axons	24092
OECs	24099
hyperplasia of glial cells , the formation of scars ,	24117
hyperplasia	24117
glial cells , the formation of scars ,	24132
glial cells	24132
the formation of scars	24145
the formation	24145
scars	24162
the loss of tissues at the injury site -LRB- Chuah et al. , 2011 -RRB-	24180
the loss	24180
tissues at the injury site -LRB- Chuah et al. , 2011 -RRB-	24192
tissues	24192
the injury site -LRB- Chuah et al. , 2011 -RRB-	24203
the injury site	24203
Chuah	24220
et al. , 2011	24226
et al.	24226
2011	24234
an ideal cell for transplantation	24255
an ideal cell	24255
transplantation	24273
OECs	24290
the second limitation	24313
MBL from autolyzing	24353
MBL	24353
autolyzing	24362
this study	24377
we	24389
MBL	24405
NSCs and OECs	24418
the lacerated ends of the injured spinal cord	24435
the lacerated ends	24435
the injured spinal cord	24457
SCI -LRB- Group F -RRB-	24490
SCI	24490
Group F	24495
We	24505
the effectiveness of this method	24522
the effectiveness	24522
this method	24543
other methods	24560
NSCs only -LRB- group B -RRB-	24588
NSCs only	24588
NSCs	24588
group B	24599
OECs only -LRB- group C -RRB-	24609
OECs only	24609
OECs	24609
group C	24620
NSCs + MBL -LRB- group D -RRB-	24630
NSCs + MBL	24630
NSCs	24630
MBL	24637
group D	24642
OECs	24656
MBL -LRB- group E -RRB-	24663
MBL	24663
group E	24668
Pathological sections	24678
group B -LRB- transplantation with NSCs only -RRB-	24703
group B	24703
transplantation with NSCs only	24712
transplantation	24712
NSCs only	24733
C -LRB- transplantation with OECs only -RRB- samples	24748
C	24748
transplantation with OECs only	24751
transplantation	24751
OECs only	24772
samples	24783
only a few transplanted cells were still alive in the grafted area	24806
only a	24806
few transplanted cells	24813
the grafted area	24856
there	24882
severe inflammation responses	24893
No regenerated axons	24924
the scar barriers	24953
This	24972
limited repair function for these 2 groups	24986
limited repair function	24986
these 2 groups	25014
groups D , E , and F	25042
groups	25042
D , E , and F	25049
MBL	25067
a larger number of grafted cells	25072
a larger number	25072
grafted cells	25091
groups B and C	25142
groups B	25142
C	25155
addition	25161
pathological sections	25171
MBL	25212
a barrier	25223
inflammatory cells	25236
some extent	25258
turn	25286
the harm	25298
grafted cells caused by inflammatory cells	25310
grafted cells	25310
inflammatory cells	25334
formation of the connection between transplanted cells and host cells	25364
formation	25364
the connection between transplanted cells and host cells	25377
the connection	25377
transplanted cells and host cells	25400
This	25435
transplantation with MBL	25456
transplantation	25456
MBL	25477
the recovery of SCI	25490
the recovery	25490
SCI	25506
rats	25513
our results	25533
BBB scoring data	25566
MBL	25598
an apparent inflammation reaction	25618
the antigen components of MBL	25660
the antigen components	25660
MBL	25686
good histocompatibility	25718
Examination of the pathological sections in group D and E	25743
Examination	25743
the pathological sections in group D and E	25758
the pathological sections	25758
group D and E	25787
NSCs in the MBL	25813
NSCs	25813
the MBL	25821
the lacerated ends	25842
the caudal region	25864
the host	25907
spinal cord tissues	25916
A larger number of living NSCs	25937
A larger number	25937
living NSCs	25956
NSCs	26004
inflammatory reactions	26023
scars	26068
the basal membrane tube	26090
These outcomes	26115
MBL	26142
the oriented growth of NSCs along its lumen	26170
the oriented growth	26170
NSCs along its lumen	26193
NSCs	26193
its lumen	26204
host cells	26229
extracellular matrix	26254
its lumen	26282
These cells	26293
a bridge	26312
nerve cell integration from the 2 lacerated ends	26332
nerve cell integration	26332
the 2 lacerated ends	26360
synaptic connections	26390
Fansa et al. -LRB- 2002 -RRB-	26412
Fansa et al.	26412
Fansa	26412
et al.	26418
2002	26426
extracellular matrix-like fibronectin and laminin	26447
extracellular matrix-like fibronectin	26447
laminin	26489
the MBL	26507
a key role	26524
cell adherence and migration	26538
laminin	26587
axon growth	26620
the lumen	26637
fibronectin	26654
the regeneration of axons	26675
the regeneration	26675
axons	26695
over-infiltration of fibroblasts	26714
over-infiltration	26714
fibroblasts	26735
group E	26759
slight inflammatory responses and cell infiltration	26774
slight inflammatory responses	26774
cell infiltration	26808
Some host nerve cells	26827
the lumen across the scars	26887
the lumen	26887
the scars	26904
This	26915
MBL	26935
a microenvironment	26950
brain-derived neurotrophic factor	26994
glial cell line-derived neurotrophic factor secreted by OECs	27032
glial cell line-derived neurotrophic factor	27032
glial cell	27032
line-derived neurotrophic factor	27043
OECs	27088
a relatively high concentration to better facilitate nerve growth	27109
nerve growth	27162
BBB scoring in the 4th week	27190
BBB scoring	27190
the 4th week	27205
rats in groups D and E	27237
rats	27237
groups D and E	27245
groups D	27245
E	27258
better recovery	27267
hind limb motor function	27286
rats in group D	27321
rats	27321
group D	27329
even better performance	27344
rats in group E	27382
rats	27382
group E	27390
the difference	27399
This	27431
there	27451
relatively smaller absolute amounts	27462
nerve cells	27501
the MBL	27531
group E	27542
some disadvantages	27561
the recovery of neural pathways between the downlink and the uplink	27590
the recovery	27590
neural pathways between the downlink and the uplink	27606
neural pathways	27606
the downlink and the uplink	27630
the downlink	27630
the uplink	27647
group F	27662
the results of morphological analysis	27671
the results	27671
morphological analysis	27686
NSCs and OECs	27725
the MBL	27746
some neural stem cells	27763
neurons	27807
These neurons in the MBL	27816
These neurons	27816
the MBL	27833
axons along the lumen	27860
axons	27860
the lumen	27872
electron microscopy results	27895
regenerative synaptic connections	27938
we	27991
demyelination	28008
the out layer of these axons	28025
the out layer	28025
these axons	28042
This	28055
OECs	28075
a limited role in myelin sheath formation	28085
a limited role	28085
myelin sheath formation	28103
the regenerative axons	28136
This shortage	28190
an important factor affecting signal transmittance between nerves	28211
an important factor	28211
signal transmittance between nerves	28241
signal transmittance	28241
nerves	28270
Consistent with this , the results of BBB scoring	28278
Consistent	28278
this , the results of BBB scoring	28294
this	28294
the results of BBB scoring	28300
the results	28300
BBB scoring	28315
rats in this group	28339
rats	28339
this group	28347
better hind limb function	28370
rats in groups A , B , C , and E	28410
rats in groups A , B , C ,	28410
rats	28410
groups A , B , C ,	28418
groups	28418
E	28438
group D	28464
there	28473
no significant difference	28483
the higher score	28517
This	28535
several factors	28558
some NSCs located in the MBL	28582
some NSCs	28582
the MBL	28603
neurons	28633
there	28645
more nerve cells	28656
the lumen	28676
group E	28703
more axons and synaptic connections	28748
more axons	28748
synaptic connections	28763
more nerve pathways	28812
group E	28840
better recovery of SCI	28855
better recovery	28855
SCI	28874
group E.	28887
demyelination of these regenerative axons	28905
demyelination	28905
these regenerative axons	28922
the transmittance of nerve signals	28990
the transmittance	28990
nerve signals	29011
it	29040
regenerative axon synaptic connections	29067
effective axons that can transmit nerve signals	29114
effective axons	29114
nerve signals	29148
This	29163
the effectiveness of the newly formed nerve pathways	29186
the effectiveness	29186
the newly formed nerve pathways	29207
there	29258
myelin sheath	29287
nerves	29316
the MBL	29326
a role on neural stem cells inducing , axon growth and synaptic connections	29352
a role	29352
neural stem cells inducing , axon growth and synaptic connections	29362
neural stem cells inducing	29362
neural stem cells	29362
axon growth	29390
synaptic connections	29406
these functions	29428
These 3 factors	29458
our results	29501
the BBB score of group F	29514
the BBB score	29514
group F	29531
that in group D	29564
that	29564
group D	29572
the difference	29585
conclusion	29624
transplantation with MBL carrying NSCs and OECs as well as MBL carrying NSCs	29636
transplantation	29636
MBL carrying NSCs and OECs as well as MBL carrying NSCs	29657
MBL	29657
NSCs and OECs as well as MBL	29670
NSCs and OECs	29670
MBL	29695
NSCs	29708
the recovery of rat neurologic function	29725
the recovery	29725
rat neurologic function	29741
SCI	29771
the outcome	29785
ideal	29815
The loading capability	29822
rat hind limbs and motor coordination ability of the hind and fore limbs	29848
rat hind limbs	29848
motor coordination ability of the hind and fore limbs	29867
motor coordination ability	29867
the hind and fore limbs	29897
addition	29957
there	29967
no substantial differences between the 2 methods tested	29978
no substantial differences	29978
the 2 methods tested	30013
the 2 methods	30013
This	30035
the grafted NSCs	30055
OECs	30076
a great extent	30112
an efficient pathway	30151
signals between these cell types	30189
signals	30189
these cell types	30205
demyelination	30234
effective synaptic connections	30266
the key points in overcoming these limitations	30304
the key points	30304
these limitations	30333
the approach	30363
the Notch	30390
pathway and Sox2	30400
Hoffmann	30418
et al. , 2014	30427
et al.	30427
2014	30435
Kim et al. , 2014	30441
Kim	30441
et al. , 2014	30445
et al.	30445
2014	30453
Koike et al. , 2014	30459
Koike	30459
et al. , 2014	30465
et al.	30465
2014	30473
Kotasová et al. , 2014	30479
Kotasová	30479
et al. , 2014	30488
et al.	30488
2014	30496
Kim et al. , 2014	30502
Kim	30502
et al. , 2014	30506
et al.	30506
2014	30514
Liu et al. , 2014	30520
Liu	30520
et al. , 2014	30524
et al.	30524
2014	30532
Additional studies	30539
these points	30580
